Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Barratt

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Pain Medicine (Malden, Mass.)|May 20, 2021
Innate Immune and Neuronal Genetic Markers Are Highly Predictive of Postoperative Pain and Morphine Patient-Controlled Analgesia Requirements in Indian but Not Chinese or Malay Hysterectomy PatientsDaniel T Barratt, Alex T Sia, Ene-Choo Tan, et al.
Plos One|September 3, 2015
Innate Immune Signalling Genetics of Pain, Cognitive Dysfunction and Sickness Symptoms in Cancer Pain Patients Treated with Transdermal FentanylDaniel T Barratt, Pål Klepstad, Ola Dale, et al.
Pharmacogenomics|June 24, 2014
Pharmacogenomics of methadone maintenance treatmentAndrew A Somogyi, Daniel T Barratt, Robert L Ali, et al.
Journal of Pharmaceutical Sciences|June 27, 2021
Instability of Efavirenz Metabolites Identified During Method Development and ValidationNatália Bordin Andriguetti, Daniel T Barratt, Joseph Tucci, et al.
Frontiers in Pharmacology|March 11, 2020
No Major Effect of Innate Immune Genetics on Acute Kidney Rejection in the First 2 Weeks Post-TransplantationRong Hu, Daniel T Barratt, Janet K Coller, et al.
The Journal of Biological Chemistry|July 11, 1998
Characterization of Pak2p, a pleckstrin homology domain-containing, p21-activated protein kinase from fission yeastM A Sells, J T Barratt, J Caviston, et al.
Clinical Pharmacology and Therapeutics|December 21, 2006
ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individualsJanet K Coller, Daniel T Barratt, Karianne Dahlen, et al.
Basic & Clinical Pharmacology & Toxicology|April 1, 2018
CYP3A5*3 and ABCB1 61A>G Significantly Influence Dose-adjusted Trough Blood Tacrolimus Concentrations in the First Three Months Post-Kidney TransplantationRong Hu, Daniel T Barratt, Janet K Coller, et al.
Pharmacogenetics and Genomics|November 30, 2018
Effect of tacrolimus dispositional genetics on acute rejection in the first 2 weeks and estimated glomerular filtration rate in the first 3 months following kidney transplantationRong Hu, Daniel T Barratt, Janet K Coller, et al.
Therapeutic Drug Monitoring|July 2, 2019
Is There a Temporal Relationship Between Trough Whole Blood Tacrolimus Concentration and Acute Rejection in the First 14 Days After Kidney Transplantation?Rong Hu, Daniel T Barratt, Janet K Coller, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Pain Medicine (Malden, Mass.)|May 20, 2021
Innate Immune and Neuronal Genetic Markers Are Highly Predictive of Postoperative Pain and Morphine Patient-Controlled Analgesia Requirements in Indian but Not Chinese or Malay Hysterectomy PatientsDaniel T Barratt, Alex T Sia, Ene-Choo Tan, et al.
Plos One|September 3, 2015
Innate Immune Signalling Genetics of Pain, Cognitive Dysfunction and Sickness Symptoms in Cancer Pain Patients Treated with Transdermal FentanylDaniel T Barratt, Pål Klepstad, Ola Dale, et al.
Pharmacogenomics|June 24, 2014
Pharmacogenomics of methadone maintenance treatmentAndrew A Somogyi, Daniel T Barratt, Robert L Ali, et al.
Journal of Pharmaceutical Sciences|June 27, 2021
Instability of Efavirenz Metabolites Identified During Method Development and ValidationNatália Bordin Andriguetti, Daniel T Barratt, Joseph Tucci, et al.
Frontiers in Pharmacology|March 11, 2020
No Major Effect of Innate Immune Genetics on Acute Kidney Rejection in the First 2 Weeks Post-TransplantationRong Hu, Daniel T Barratt, Janet K Coller, et al.
The Journal of Biological Chemistry|July 11, 1998
Characterization of Pak2p, a pleckstrin homology domain-containing, p21-activated protein kinase from fission yeastM A Sells, J T Barratt, J Caviston, et al.
Clinical Pharmacology and Therapeutics|December 21, 2006
ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individualsJanet K Coller, Daniel T Barratt, Karianne Dahlen, et al.
Basic & Clinical Pharmacology & Toxicology|April 1, 2018
CYP3A5*3 and ABCB1 61A>G Significantly Influence Dose-adjusted Trough Blood Tacrolimus Concentrations in the First Three Months Post-Kidney TransplantationRong Hu, Daniel T Barratt, Janet K Coller, et al.
Pharmacogenetics and Genomics|November 30, 2018
Effect of tacrolimus dispositional genetics on acute rejection in the first 2 weeks and estimated glomerular filtration rate in the first 3 months following kidney transplantationRong Hu, Daniel T Barratt, Janet K Coller, et al.
Therapeutic Drug Monitoring|July 2, 2019
Is There a Temporal Relationship Between Trough Whole Blood Tacrolimus Concentration and Acute Rejection in the First 14 Days After Kidney Transplantation?Rong Hu, Daniel T Barratt, Janet K Coller, et al.
Pageof 4